| abstract |
The present invention relates to the variant of plasminogen and fibrinolysin, these variants include one or more point mutation at catalyst structure domain, these point mutation reduce or prevent fibrinolysin proteinase activity self-catalysis destroy.Further disclose the described plasminogen of use and the compositions of variant, purposes and the method for fibrinolysin. |